Criticaleye recently caught up with Abbas Hussain, President, Emerging Markets at GlaxoSmithKline, to discuss the state of emerging markets and the initial stages of GSK’s low-cost drug plan, a revolutionary scheme set to change the face of the pharmaceutical industry.
Read, watch & listen to some of the latest thought leadership from our Community.
VIEWPOINTS | The Sustainability Reset
There’s no doubt that the external narrative around sustainability has shifted over the last 18 months, but behind the scenes companies continue to navigate the challenges and opportunities associated with the ...
BLOG | Transforming Your Sustainability Strategy
Sustainability remains firmly on the agenda for most organisations, but the way leaders are approaching it is changing. What used to be driven by bold, standalone commitments are now shifting towards a more grounded ...
Mike Maudsley, CEO of enfinium: How Great CEOs Stay Ahead of the Curve
Mike Maudsley, CEO of enfinium, joins Bridgette Hall, Senior Editor at Criticaleye, to explore what it takes to succeed as a CEO in today’s fast-changing business environment. As organisations navigate incr...
Displaying 1 to 3 of 200
We use cookies to improve your experience. By using our site, you agree to our use of cookies.
